Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients

被引:3
|
作者
Czibor, Sandor [1 ]
Carr, Robert [2 ]
Redondo, Francisca [3 ]
Auewarakul, Chirayu U. [4 ]
Cerci, Juliano J. [5 ]
Paez, Diana [6 ]
Fanti, Stefano [7 ]
Gyorke, Tamas [1 ]
机构
[1] Semmelweis Univ, Med Imaging Ctr, Dept Nucl Med, Budapest, Hungary
[2] Kings Coll London, Guys & St Thomas Hosp, Dept Hematol, London, England
[3] Fdn Arturo Lopez Perez, Oncol Clin, Santiago, Chile
[4] Chulabhorn Royal Acad, HRH Princess Chulabhorn Coll Med Sci, Fac Med & Publ Hlth, Bangkok, Thailand
[5] PET CT Dept Quanta Diagnost & Terapia, Curitiba, Brazil
[6] IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
[7] Univ Bologna, Policlin S Orsola, Metropolitan Nucl Med, Bologna, Italy
关键词
diffuse large B-cell lymphoma; Deauville score; PET; metabolic tumor volume; ratio PET; METABOLIC TUMOR VOLUME; PROGRESSION-FREE SURVIVAL; HODGKIN-LYMPHOMA; RESPONSE ASSESSMENT; FDG-PET/CT; PREDICTION; CRITERIA; IPI;
D O I
10.1097/MNM.0000000000001664
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective2-[F-18]fluoro-2-deoxy-d-glucose PET/computed tomography ([F-18]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. MethodsWe investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (Delta SUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. ResultsA total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different.Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, Delta SUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that Delta SUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). ConclusionBaseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative 'Deauville-like' parameters performing best in the present study.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 50 条
  • [41] Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma
    Huntington, Scott F.
    Nasta, Sunita D.
    Schuster, Stephen J.
    Doshi, Jalpa A.
    Svoboda, Jakub
    LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2579 - 2584
  • [42] Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma
    Wight, Joel
    Wai, Shin Hnin
    Shen, Edward
    Lee, Sze-Ting
    Berlangieri, Salvatore
    Fancourt, Tineke
    Hawkes, Eliza
    Hannah, Anthony
    Leung, Teresa
    Chong, Geoffrey
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 475 - 483
  • [43] [18F]FDG PET/CT biomarkers in patients with Relapsed/ Refractory Diffuse Large B-cell Lymphoma treated with Loncastuximab tesirine
    Zanca, R.
    Improta, C. M.
    Magagnoli, M.
    Mazza, R.
    Rodari, M.
    Carlo-Stella, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S579 - S579
  • [44] Prognostic significance of interim 18F-FDG PET/CT SUV reduction associated with Ki67 in patients with diffuse large B-cell lymphoma
    孙一文
    赵晋华
    乔文礼
    邢岩
    陈香
    宋建华
    NuclearScienceandTechniques, 2014, 25 (02) : 43 - 49
  • [45] A case of lymphangioleiomyomatosis with diffuse large B-cell lymphoma: Usefulness of FDG-PET
    Orimo, Mami
    Kondo, Mitsuko
    Takeyama, Kiyoshi
    Masui, Kenta
    Tanaka, Junji
    Tagaya, Etsuko
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 29
  • [46] Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
    Itti, Emmanuel
    Lin, Chieh
    Dupuis, Jehan
    Paone, Gaetano
    Capacchione, Daniela
    Rahmouni, Alain
    Haioun, Corinne
    Meignan, Michel
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (04) : 527 - 533
  • [47] Prognostic significance of interim 18F-FDG PET/CT SUV reduction associated with Ki67 in patients with diffuse large B-cell lymphoma
    Sun Yi-Wen
    Zhao Jin-Hua
    Qiao Wen-Li
    Xing Yan
    Chen Xiang
    Song Jian-Hua
    NUCLEAR SCIENCE AND TECHNIQUES, 2014, 25 (02)
  • [48] Clinical scoring systems, molecular subtypes and baseline [18F]FDG PET/CT image analysis for prognosis of diffuse large B-cell lymphoma
    Sun, Zhuxu
    Yang, Tianshuo
    Ding, Chongyang
    Shi, Yuye
    Cheng, Luyi
    Jia, Qingshen
    Tao, Weijing
    CANCER IMAGING, 2024, 24 (01)
  • [49] Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma
    Zhou, Mingge
    Chen, Yumei
    Huang, Honghui
    Zhou, Xiang
    Liu, Jianjun
    Huang, Gang
    ONCOTARGET, 2016, 7 (50) : 83544 - 83553
  • [50] Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma
    Coskun, Nazim
    Okudan, Berna
    Uncu, Dogan
    Kitapci, Mehmet Tevfik
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (11) : 1227 - 1232